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Introduction 
Thoracic aortic aneurysm is an important cause of
mortality due to rupture or dissection, in which
ascending aortic aneurysm accounts for 40% of diag-
nosed patients [1,2]. Ascending aortic aneurysm has
been shown to be associated with degeneration of the
arterial tunica media, congenital cardiovascular mal-
formations, connective tissue disorders, and aortic dis-
section [3]. Ascending aortic aneurysm initially was
described as a non-inflammatory lesion. However,
recent evidence indicates that the infiltration of
inflammatory cells contributes to the pathogenesis of
ascending aortic aneurysms [4,5]. 
It has been demonstrated that inflammatory mark-
ers were associated with cardiovascular disease, sug-
gesting that inflammation plays a key role in the initi-
ation and progression of cardiovascular disease [1,6].
The release of proinflammatory molecules induces the
accumulation of monocytes, smooth muscle cells, and
lymphocytes within the arterial wall, resulting in the
formation of atherosclerotic plaque, eventually leading
to complications, such as total artery occlusion, rup-
ture, calcification, or aneurysm [7,8]. Aneurysmal and
atherosclerotic arteries are characterized by infiltration
of leukocytes, particularly macrophages and T cells,
which elicit immune responses and vascular disease
[9-13]. Infiltrating inflammatory cells release many
inflammatory cytokines and promote the production of
matrix metalloproteinases (MMPs) [14]. Recent stud-
ies have shown that MMPs are related to aortic
aneurysm formation, particularly MMP-2 and MMP-9. 
Several molecules play a key role in the inflamma-
tory cascade. Adhesion molecules, vascular cell adhe-
sion molecule-1 (VCAM-1) and intercellular adhesion
molecule-1 (ICAM-1), play a significant role in ensur-
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Abstract: Recent studies have suggested that inflammation actively participates in ascending aortic aneurysm formation.
The aim of the present study was to evaluate the expression changes of adhesion molecules and MMPs in an experimental
model of ascending aortic aneurysm induced by ascending aorta banding in Wistar rats. Twelve rats developed aortic dila-
tion after ascending aorta banding treatment, while nine normal animals underwent surgery without banding were used as
controls. Light microscope and scanning electron microscope showed that the wall of the ascending aorta became disor-
ganized as well as infiltration by inflammatory cells in aneurysmal rats. By using immunohistochemical techniques, a sig-
nificant increase in the immunostaining of MCP-1 was observed in the aneurysmal wall as compared to the normal aortic
wall. Under similar experimental conditions, we also found that the immunostaining of ICAM-1 and VCAM-1 was marked-
ly increased in the aneurysmal wall. In addition, gelatin zymographic analysis showed that the expression and acitivities of
MMP-2 and MMP-9 were remarkably enhanced in the ascending aorta of ascending aortic aneurysmal rats as compared to
normal rats. These results demonstrate that MCP-1, ICAM-1 and VCAM-1 are involved in the pathogenesis of ascending
aortic aneurysm and an increase in the immunostaining and activity of MMP-2 and MMP-9 may promote the progression
of ascending aortic aneurysm.
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ing the recruitment of inflammatory cells. Their role in
inflammation is linked to leukocyte attachment,
rolling, and trans-endothelial migration. The ICAM-1,
an immunoglobulin-like molecule, was expressed very
low in endothelial cells, while its expression was
markedly increased with exposure to inflammatory
cytokines. VCAM-1 has been shown to be involved in
accumulation and adhesion of leukocytes primarily by
interacting with its counterligand VLA-4 in monocytes
and lymphocytes [15]. Monocyte chemoattractant pro-
tein-1 (MCP-1) belongs to the CC chemokine family
and is a potent agonist for monocytes, T lymphocytes,
natural killer cells, and basophils [16].
However, few studies have focused on inflammatory
disease of the proximal aorta and the mechanism for
pathogenesis of ascending aortic aneurysm is still not
completely understood. A clear understanding of these
events is critical for mechanistic and therapeutic
exploitation in ascending aortic aneurysm. Our previous
studies have demonstrated that ascending aortic dilation
was induced by banding the ascending aorta [17,18].
The aim of this study was to follow morphological
changes and determine the immunohistochemical
localization of MCP-1, ICAM-1 and VCAM-1 in the
early aneurysmal dilatation, which could provide evi-
dence that these proteins contribute to the develop-
ment of ascending aortic aneurysm.
Materials and methods 
Animal use and surgical procedure. Young female Wistar rats
(80-100g, provided by the experimental animal center of China
Medical University) were used in the study. All animal experi-
ments were carried out in accordance with the ethical standards of
China Medical University. The models (n=12) were established as
previously described [17,18]. Briefly, animals were anesthetized
with pentobarbital sodium (40 mg/kg, intraperitoneally) and con-
nected to a rodent ventilator (Jiang Wan II) set at a respiratory rate
of 100 strokes per minute with a tidal volume of 3 ml. The animal
was then carefully rotated to the left lateral decubitus position,
exposing the right chest. A sterile thoracotomy was performed
between the second and third interspace, the ascending aorta was
dissected free of the pulmonary artery, and a flexible polyethylene
tube (7mm diameter) with a 4-0 silk suture was placed around the
aortic root (The average perimeter of the ascending aorta is 7 mm
in live young female Wistar rats). After the chest was closed, ani-
mals were given an injection of antibiotics agent (Penicillin 10,000
U i.m.) for 3 days. Sham-operated animals (n=9) underwent sur-
gery without banding. About 30% of animals that underwent sur-
gery died either just after surgery or during the overall period of
aneurysmal dilation. The animals were housed in a temperature-
controlled room under normal 12h light/12h dark laboratory con-
ditions with free access to chow and water.  Previous studies have
shown successful induction of aneurysms in the descending aorta
of monkeys after the initial procedure [19]. The aneurysmal degen-
eration could be seen at 8 weeks after the surgery.
Ultrasonography. Ultrasonography was performed to demonstrate
dilatation of the ascending aortas. In this study, 21 anesthetized rats
were placed on a rat bed in a shallow left lateral decubitus position.
Transthoracic echocardiography was performed using a pediatric
broadband 6-15 MHz linear array ultrasound transducer. For an
accurate measurement of aortic diameter, we calculated aneurysm
diameters using SZH light microscopy at aortic harvest. 
Harvesting procedures. After ultrasonography detection, the ani-
mals were re-anesthetized and the initial incisions were re-opened.
The circulatory system was perfused with normal saline. Then the
aortas were harvested. The samples were either frozen in liquid
nitrogen or fixed in neutral buffered formalin or glutaraldehyde.
For each subject, one part of aneurysm was used for histologic
examination and the other part of aneurysm was used for gelatin
zymography studies. 
Staining. Fixing samples were dehydrated through ethanol and
embedded in paraffin for sectioning. Aortic tissue cross-sections 
(5 μm) of rats were stained with hematoxylin and eosin (H&E) for
general tissue morphology in the standard manner. The change of
elastic lamellar was observed by Romeis staining.
Scanning Electron Microscopy. The samples were postfixed in
2.5% glutaraldehyde solution for 12 hours, followed by overnight
in 0.1mol/L PBS (pH 7.2), all at room temperature. The tissues
were next dehydrated in ethanol, critical point-dried with CO2 and
sputter-coated with gold palladium. A standardized area of each
specimen was then examined in a blinded fashion with scanning
electron microscope (JSM-T300).
Immunohistochemistry. Anti-CD45 (1:200, Boisynthesis, China),
anti-VCAM-1 (1:100, Boster, China), anti-ICAM-1(1:100, Boster,
China), anti-MCP-1 (1:100, Santa Cruz Biotech, Santa Cruz, CA,
USA) were used for analysis. Immunohistochemical staining was
performed using the strept-avidin biotin complex (SABC) test
method. Diluted primary antibodies (1:200) were then applied to
the sections, and these sections were incubated overnight at 4°C.
Immune complexes were visualized using 3, 3'-diaminobenzidine
(DAB), and slides were counterstained with hematoxylin. All sec-
tions were then dehydrated in graded alcohols and covered by cov-
erslips with neutral balsam for light microscopy. For negative con-
trol experiments, the primary antibody was omitted and processed
as described above. Non-specific staining was not observed. For all
sections, we assessed the mean optical density.
Gelatin zymography. Frozen aortic tissues were homogenized
and total proteins extracted. Tissue proteins were subjected to
SDS-PAGE using 7.5% acrylamide gels containing 0.1% gelatin.
The gels were then incubated for 30 min at room temperature in
2.5% Triton X-100, agitated on a rocking bed, and then transferred
to activation buffer (50 mM Tris-Cl pH 7.5, 10 mM CaCl2, 200
mmol/L NaCl, 1 μmol/L ZnCl2) for 18 hours incubation at 37°C.
Gels were then stained with 0.1% Coomassie Brilliant Blue R-250
for 4 hour and briefly destained in 10% acetic acid and 40%
methanol for 0.5-1 hour. Gelatinolytic activity was detected as
transparent bands on a blue background. Gels were scanned and
integrated density values (IDVs) were calculated by Fluor Chen
2.0 software.
Statistical analysis. SPSS 13.0 statistical software was used for
statistical analysis. The Mann Whitney test was used for data
analysis, p<0.05 was considered statistically significant.
Results
Morphologic changes of the ascending aorta in
Wistar rats with ascending aortic dilatation
To investigate the formation mechanism of ascending
aortic aneurysm, we established an animal model of
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ascending aortic aneurysm in rats. Using ultrasonic
and histological techniques, we studied the changes of
morphology and hemodynamics in the dilated aorta. At
8 weeks after surgery, ultrasonography was performed
on the rats. There was no dilation in the ascending aor-
tas in the sham-operated group and the aortas were
round and smooth. However, remarkable dilation was
observed in the ascending aortas of the operated group,
and the region of dilation was localized above the aor-
tic banding ring. We found that after operation the aor-
tas had a 44.26% increase in diameter as compared to
sham group (sham group, 3.39±0.15 mm; operated
group, 2.35±0.05 mm, p<0.05) (Fig. 1, Fig. 2). With an
arbitrary threshold of a 20% diameter increase consid-
ered aneurysmal dilation in this experimental model, 8
of 12 rats exhibited aneurysms in the operated group
(66.67%).                              
The histological changes of the dilated aorta were
examined by light microscopy and scanning electron
microscopy. HE staining showed that three layers,
tunica intima, tunica media and tunica adventitia, were
clearly observed in the normal ascending aortic wall
(Fig. 3a). However, the aortic wall in the operated
group was disorganized and infiltrated by many
inflammatory cells (Fig. 3b). In parallel with aortic
dilatation, major changes were accompanied in vascu-
lar elastin integrity as shown by Romeis staining.
Compared with the sham-operated group (Fig. 3c),
aortic elastin in the operated group exhibited charac-
teristic flattening and fragmentation (Fig. 3d). Some-
times, the fragmented elastic laminae were infiltrated
by inflammatory cells (Fig. 3e, f).
Expression of CD45, MCP-1, ICAM-1 and
VCAM-1 in the ascending aorta
To evaluate vascular inflammation, immunostaining of
CD45+ (pan-leukocyte marker) was conducted. The
density of leukocytes was determined by counting the
mean number of nuclei surrounded by positive
immunostaining within 400× high power fields (HPF).
In the normal arterial wall, CD45+ expression was only
slightly detected in the intima of the vascular wall. In
contrast, in aneurysmal aorta, CD45+ cells were pres-
ent in all layers of the vascular wall, suggesting
aneurysmal aortas had greater infiltration as compared
to normal aortas (Fig. 4).
To determine the immunolocalization of MCP-1,
ICAM-1 and VCAM-1 in the ascending aorta,
immunohistochemical staining techniques were used.
There was very little immunostaining of MCP-1,
ICAM-1 and VCAM-1 in the normal ascending aorta
(Fig. 5a1, b1, c1). In the operated group, the immunos-
taining of MCP-1 was markedly increased and local-
ized in the intima of the ascending aorta (Fig. 5a2).
Most VCAM-1 immunostaining was mainly localized
in the endothelium of the neointimal thickening
regions (Fig. 5b2). ICAM-1 was most intensively
immunostained in the luminal endothelium, while the
immunostaining was scattered in the media and adven-
titia of the ascending aorta (Fig. 5c2). The mean opti-
cal density of MCP-1, ICAM-1 and VCAM-1 was sig-
nificantly increased in the operated group as compared
to the sham group (Fig. 5d).
Expression of MMP-2 and MMP-9
In a variety of MMPs, MMP-2 and MMP-9 have been
considered to be especially important in the pathogen-
esis of the aortic aneurysm [20,21]. Gelatin zymogra-
phy is a sensitive technique that detects activated gel-
atin-degrading metalloproteinases. The activity and
expression of MMP-2 and MMP-9 of operated group
was significantly increased compared with the sham
group (Fig. 6). These results indicate that MMP-2 and
MMP-9 are involved in the development of aneurysm.
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Fig. 1. Representative ultrasound
images show aortic dilatation. 
a. The normal rat ascending aorta. 
b. Operated group, arrowheads
show the site of banding. c. Operat-
ed group, the dilated ascending
aorta
Fig. 2. Comparison of sham-operated and operated rat ascending
aortic diameter. *p<0.05 versus sham ascending aorta.
Discussion 
A strong relationship between vascular inflammation
and the progression of abdominal aortic aneurysm has
been reported from clinical findings and animal exper-
iments [22,23]. While the immunological mechanisms
underlying atherosclerosis and abdominal aortic
aneurysm have been somewhat characterized, little is
known about the role of inflammatory cells, cytokines,
and cell adhesion molecules in the pathogenesis of
ascending aortic aneurysm. In this study, we used
experimental aneurysms in rat to study the immunolo-
calization of some cellular and extracellular molecules
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Fig.  3. Histology of rat aorta. 
a. HE staining shows the wall of the
normal ascending aorta. b. HE
staining shows the wall of the dilat-
ed ascending aorta. c. Romeis stain-
ing shows elastic lamellae in the
wall of the normal ascending aorta.
d. Romeis staining shows elastic
lamella in the wall of the dilated
ascending aorta. e. The inflammato-
ry cells infiltrating the wall of the
dilated ascending aorta. f. The
inflammatory cells infiltrating the
fragmented sites of the elastic
lamella of the dilated ascending
aorta. Scale bars: 50 µm (a-d) and 
1 µm (e, f), (n=5).
Fig. 4. Immunohistochemical stain-
ing of CD45 (a, b) and number of
migrated leukocytes in vessel wall
after 8 weeks of treatment (c).
Brown deposits indicate positive
staining. a. The wall of the normal
ascending aorta. b. The wall of the
dilated ascending aorta. AL:  aortic
lumen, Scale bars: 50 μm. (n=8)
Fig. 5. Immunohistochemical staining of MCP-1, VCAM-1 and ICAM-1. Brown deposits indicate positive staining. a1, a2. Immunostaining
of MCP-1. b1, b2. Immunostaining of VCAM-1. c1, c2. Immunostaining of ICAM-1. a1, b1, c1. The wall of the normal ascending aorta. a2,
b2, c2. The wall of the dilated ascending aorta.  AL: aortic lumen, Scale bars: 50 μm. d. Comparison of MCP-1, VCAM-1 and ICAM-1 mean
optical density values of sham group and operated group. All values are mean ±standard deviation (SD) (n=6). *p<0.05 versus sham group.
Fig. 6. Gelatin zymographic analysis of protein levels of MMP-2
and MMP-9 in the rat aorta (a). The densitometric analysis show-
ing that the activity and expression of MMP-2 and MMP-9 of the
operated group was significantly enhanced compared with the
sham group (b). All values are mean ±standard deviation (SD)
(n=5). *p<0.05 versus sham group, **p<0.01 versus sham group.
involved in the vascular remodeling of aneurysms.
Banding of the ascending aorta of rats resulted in
enlargement of the vessel. Specific arterial sites, such
as branches, bifurcations, and curvatures, cause char-
acteristic alterations in the flow of blood, including
decreased shear stress and increased turbulence [24].
Cynomolgus monkeys that underwent mid-thoracic
aortic coarctation led to produce post-stenotic dilata-
tion [19]. Post-stenotic dilatation of the ascending
aorta is seen in patients with aortic stenosis and/or aor-
tic regurgitation [25]. This dilatation is usually pro-
gressive and may undergo aneurysmal degeneration
with disruption of the artery wall [26]. The aorta has
multiple cellular origins in the developing embryo.
The origination of ascending aorta is different from the
descending thoracic and abdominal aorta [27]. Thus,
the present results extend the post-stenotic dilatation
for the study of ascending aortic aneurysms.
In the present study, our results demonstrated that
the formation of dilated ascending aorta in this model
was associated with the expression of MCP-1, ICAM-
1, VCAM-1, and MMPs and infiltration of inflamma-
tory cells. We found many inflammatory cells in
aneurysm walls from histological evidence and
immunohistochemical staining of CD45. CD45+ cells
were present in all layers of the vascular wall. Recent
studies revealed that inflammation contributed to
ascending aortic aneurysm formation. Immunohisto-
chemical studies in ascending aortic aneurysm demon-
strated that the numbers of T lymphocytes and
macrophages were increased compared with normal
aortas [4,5].
The expression of leukocyte adhesion molecules on
endothelial cells, such as ICAM-1 and VCAM-1, plays
an important role in the mediation of the location of
monocytes at the intimal surface [21,28-30]. From our
observations of ICAM-1 and VCAM-1 immunolocal-
ization in ascending aortic tissues, very low or no
expression of ICAM-1 and VCAM-1 was seen in nor-
mal ascending aortas, but in situ ICAM-1 and VCAM-
1 expression was significantly increased in aneurysmal
dilatation tissues. The enhanced expressions of ICAM-
1 and VCAM-1 in aneurysmal dilatation tissues con-
firm the involvment of inflammation in aneurysm. The
expression of VCAM-1 was up-regulated in the
endothelium of rat cerebral aneurysms in the early
stage of cerebral aneurysm formation, while inhibiting
the upregulation of VCAM-1 expression in aneurys-
mal walls, consequently led to reduction of
macrophage infiltration into aneurysmal walls [31].
Elevated levels of VCAM-1 on the vessel endothelial
surface may play an important role in ascending aortic
aneurysm development by leukocytes recruitment.
ICAM-1 interacts with leukocytes principally by bind-
ing to the surface membrane beta-2 integrin molecule,
LFA-1 [32]. ICAM-1 expression was up-regulated in
abdominal aortic aneurysm compared with normal
aortic tissues [30]. In our results, endothelial expres-
sion of ICAM-1 may be involved in the recruitment of
leucocytes to the lesion as suggested by its role in the
entry of leukocytes into foci of inflammation. 
In atherosclerosis, endothelial dysfunction induces
monocyte recruitment by transcriptional regulation of
various proinflammatory genes, such as ICAM-1 and
VCAM-1 [28,29,33]. Although the role of endothelial
cells in ascending aortic aneurysm formation has not
yet been established, a similar mechanism may be
involved in the initiation of ascending aortic aneurysm
formation. We observed that MCP-1 was increased and
localized in the intima of the ascending aorta in the
operated group. MCP-1 is related to monocyte/
macrophage recruitment, which accumulates in the
injured region in various vascular diseases, such as
atherosclerosis [34,35] and abdominal aortic aneurysm
[36-38]. MCP-1-/- mice exhibited a significant
decrease in cerebral aneurysm formation and
macrophage accumulation as well as a decrease in the
expression of MMP-2 and MMP-9 [39]. Our data sug-
gest that MCP-1 may play important roles in ascend-
ing aortic aneurysm formation by recruiting mono-
cyte/macrophage into aneurysmal wall.
In addition to dilatation, damage of arterial elastin
is also a pathogenic aspect characteristic of the ascend-
ing aortic aneurysms. We noted that activation and
expression of MMP-2 and MMP-9 in the arterial walls
of early aneurysmal changes was detected at 8 weeks
of aneurysm induction with the enhanced expression
of MCP-1, ICAM-1 and VCAM-1. These findings
suggest that an active vascular response is present in
the early aneurysmal dilatation. MMPs are calcium-
and zinc-dependent endopeptidases, are able to
degrade extracellular components and play a funda-
mental role in tissue remodeling [40]. Recently, we
have demonstrated that MMP-2, MMP-3 and MMP-9
were activated in 3-5 months after ascending aortic
aneurysm induction [17,18]. In the transwell experi-
ment, the up-regulation of MMP-9 in T lymphoma
cells upon contacting with endothelium required
ICAM-1-mediated adhesion [41]. In atherogenesis, the
expression and activity of MMP-2 and MMP-9 was
up-regulated by VCAM-1, while MMP inhibitors
blocked this act [42]. 
To further clarify the role of MCP-1, ICAM-1 and
VCAM-1 in ascending aortic aneurysm formation,
knock-out animal models will be used in the future
studies. In summary, the data presented in this study
provide further evidence to prove that inflammatory
processes are involved in the pathogenesis of ascend-
ing aortic aneurysm.
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